PSCs and GLP-1R: Occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist

Laboratory Investigation

Volumn 94, Issue 1, 2014, Pages 63-78

  Nakamura, Taichi ^a,b   Ito, Tetsuhide ^a   Uchida, Masahiko ^a   Hijioka, Masayuki ^a   Igarashi, Hisato ^a   Oono, Takamasa ^a   Kato, Masaki ^a   Nakamura, Kazuhiko ^a   Suzuki, Koichi ^c   Jensen, Robert T ^b   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

diabetes mellitus; GLP 1 receptor; glucagon like peptide 1; liraglutide; pancreatic stellate cells; pancreatitis; proliferation

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MTS ASSAY; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET CELL; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCAGON-LIKE PEPTIDE 1; HISTOCYTOCHEMISTRY; HYPOGLYCEMIC AGENTS; MALE; PANCREAS; PANCREATIC STELLATE CELLS; PANCREATITIS, ACUTE NECROTIZING; PANCREATITIS, CHRONIC; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 84891554437     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.133     Document Type: Article

References (81)

1. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-Analysis. J Am Med Assoc 2007;298:194-206
2. Drucker DJ, Nauck MA. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-1705
3. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008;60:470-512
4. Seino Y, Rasmussen MF, Nishida T, et al. Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in japanese patients with type 2 diabetes. Curr Med Res Opin 2010;26:1013-1022
5. Butler PC, Dry S, Elashoff R. GLP-1-based therapy for diabetes: What you do not know can hurt you. Diabetes Care 2010;33:453-455
6. Butler PC, Matveyenko AV, Dry S, et al. Glucagon-like peptide-1 therapy and the exocrine pancreas: Innocent bystander or friendly fire?. Diabetologia 2010;53:1-6
7. Elashoff M, Matveyenko AV, Gier B, et al. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1based therapies. Gastroenterology 2011;141:150-156
8. Knezevich E, Crnic T, Kershaw S, et al. Liraglutide-Associated acute pancreatitis. Am J Health Syst Pharm 2012;69:386-389
9. Butler AE, Galasso R, Matveyenko A, et al. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia 2010;53:21-26
10. Gier B, Matveyenko AV, Kirakossian D, et al. Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the kras(G12D) mouse model. Diabetes 2012;61: 1250-1262
11. Iyer SN, Drake 3rd AJ, West RL, et al. Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide. Endocr Pract 2012;18:e10-e13
12. Famularo G, Gasbarrone L, Minisola G. Pancreatitis during treatment with liraglutide. JOP 2012;13:540-541
13. Lee PH, Stockton MD, Franks AS. Acute pancreatitis associated with liraglutide. Ann Pharmacother 2011;45:e22
14. Franks AS, Lee PH, George CM. Pancreatitis: A potential complication of liraglutide?. Ann Pharmacother 2012;46:1547-1553
15. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother 2010;44:904-909
16. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-2157
17. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439
18. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379: 69-72
19. Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 1996;137:2968-2978
20. Gorelick FS. Pancreas cell physiology and pancreatitis cell biology: Summary of a symposium held at the joint meeting of the EPC and the IAP, heidelberg 2002. Pancreatology 2003;3:207-208
21. Hoque R, Sohail M, Malik A, et al. TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology 2011;141:358-369
22. Hoque R, Malik AF, Gorelick F, et al. Sterile inflammatory response in acute pancreatitis. Pancreas 2012;41:353-357
23. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol 1977;373:97-117
24. Vonlaufen A, Apte MV, Imhof BA, et al. The role of inflammatory and parenchymal cells in acute pancreatitis. J Pathol 2007;213:239-248
25. Pandol SJ, Raraty M. Pathobiology of alcoholic pancreatitis. Pancreatology 2007;7:105-114
26. Erkan M, Adler G, Apte MV, et al. StellaTUM: Current consensus and discussion on pancreatic stellate cell research. Gut 2012;61:172-178
27. Omary MB, Lugea A, Lowe AW, et al. The pancreatic stellate cell: A star on the rise in pancreatic diseases. J Clin Invest 2007;117:50-59
28. Pandol S, Gukovskaya A, Edderkoui M, et al. Epidemiology, risk factors, and the promotion of pancreatic cancer: Role of the stellate cell. J Gastroenterol Hepatol 2012;27(Suppl 2):127-134
29. Andoh A, Takaya H, Saotome T, et al. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 2000;119:211-219
30. Masamune A, Kikuta K, Watanabe T, et al. Pancreatic stellate cells express Toll-like receptors. J Gastroenterol 2008;43:352-362
31. Uchida M, Ito T, Nakamura T, et al. ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells. Lab Invest 2013;93:41-53
32. Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture. Gut 1998; 43:128-133
33. Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-432
34. Charo C, Holla V, Arumugam T, et al. Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas 2012;42: 467-474
35. Hama K, Ohnishi H, Yasuda H, et al. Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem Biophys Res Commun 2004;315: 905-911
36. Reinehr R, Zoller S, Klonowski-Stumpe H, et al. Effects of angiotensin II on rat pancreatic stellate cells. Pancreas 2004;28:129-137
37. Yamada T, Kuno A, Masuda K, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307:17-23
38. Berna MJ, Seiz O, Nast JF, et al. CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production. J Biol Chem 2010;285:38905-38914
39. Phillips PA, Yang L, Shulkes A, et al. Pancreatic stellate cells produce acetylcholine and may play a role in pancreatic exocrine secretion. Proc Natl Acad Sci USA 2010;107:17397-17402
40. Tashiro M, Ernst SA, Edwards J, et al. Hyperthermia induces multiple pancreatic heat shock proteins and protects against subsequent arginine-induced acute pancreatitis in rats. Digestion 2002;65:118-126
41. Akimoto T, Nakama K, Katsuta Y, et al. Characterization of a novel congenic strain of diabetic fatty (WBN/Kob-lepr(fa)) rat. Biochem Biophys Res Commun 2008;366:556-562
42. Ohashi K, Kim JH, Hara H, et al. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 1990;6: 231-247
43. Nakamura T, Ito T, Oono T, et al. Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: Potential mechanisms for bacterially induced fibrosis. Pancreas 2011;40: 823-831
44. Nakamura T, Ito T, Igarashi H, et al. Cytosolic double-stranded DNA as a damage-Associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: A plausible mechanism for tissue injury-Associated pancreatitis. Int J Inflam 2012;2012:504128
45. Hörsch D, Göke R, Eissele R, et al. Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 1997;14:290-294
46. Goke R, Oltmer B, Sheikh SP, et al. Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes. FEBS Lett 1992;300:232-236
47. Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 1997;46:785-791
48. Dillon JS, Lu M, Bowen S, et al. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release. Exp Clin Endocrinol Diabetes 2005;113:182-189
49. Kedees MH, Grigoryan M, Guz Y, et al. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia. Mol Cell Endocrinol 2009;311:69-76
50. Masamune A, Kikuta K, Satoh M, et al. Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J Exp Med 2003;199:69-84
51. Koehler JA, Baggio LL, Lamont BJ, et al. Glucagon-like peptide-1 receptor activation modulates pancreatitis-Associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 2009;58:2148-2161
52. Tatarkiewicz K, Smith PA, Sablan EJ, et al. Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents. Am J Physiol Endocrinol Metab 2010;299: E1076-E1086
53. Alves C, Batel-Marques F, Macedo AF. A meta-Analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer. Diabetes Res Clin Pract 2012;98:271-284
54. Moens K, Heimberg H, Flamez D, et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996;45:257-261
55. Abrahamsen N, Nishimura E. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids. Endocrinology 1995;136:1572-1578
56. Rosselin G, Leclercq-Meyer V, Boissart C, et al. GLP-1 receptors in golden syrian hamster islets: Identification and functional characterization. Endocrine 1998;8:323-330
57. Huypens P, Ling Z, Pipeleers D, et al. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 2000;43:1012-1019
58. Goke R, Conlon JM. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. J Endocrinol 1988;116:357-362
59. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 1992;89:8641-8645
60. Raufman JP, Singh L, Singh G, et al. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. identification of a mammalian analogue of the reptilian peptide exendin-4. J Biol Chem 1992;267:21432-21437
61. Zhou J, Montrose-Rafizadeh C, Janczewski AM, et al. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells. J Cell Physiol 1999;181:470-478
62. Hirata Y, Kurobe H, Nishio C, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Eur J Pharmacol 2012;699:106-111
63. Neuschwander-Tetri BA, Bridle KR, Wells LD, et al. Repetitive acute pancreatic injury in the mouse induces procollagen alpha1(I) expression colocalized to pancreatic stellate cells. Lab Invest 2000;80: 143-150
64. Gonzalez AM, Garcia T, Samper E, et al. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011;301:G846-G855
65. Shimizu K, Kobayashi M, Tahara J, et al. Cytokines and peroxisome proliferator-Activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 2005;128:2105-2118
66. Kuno A, Yamada T, Masuda K, et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male wistar Bonn/Kobori rats. Gastroenterology 2003;124:1010-1019
67. Klonowski-Stumpe H, Reinehr R, Fischer R, et al. Production and effects of endothelin-1 in rat pancreatic stellate cells. Pancreas 2003;27: 67-74
68. Masamune A, Kikuta K, Satoh M, et al. Protease-Activated receptor-2-mediated proliferation and collagen production of rat pancreatic stellate cells. J Pharmacol Exp Ther 2005;312:651-658
69. Shiraki A, Oyama J, Komoda H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-Alpha-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis 2012;221:375-382
70. Pugazhenthi U, Velmurugan K, Tran A, et al. Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: Potential therapeutic benefits in diabetic patients. Diabetologia 2010;53:2357-2368
71. Iwai T, Ito S, Tanimitsu K, et al. Glucagon-like peptide-1 inhibits LPSinduced IL-1beta production in cultured rat astrocytes. Neurosci Res 2006;55:352-360
72. Buteau J, Foisy S, Rhodes CJ, et al. Protein kinase czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 2001;50:2237-2243
73. Friedrichsen BN, Neubauer N, Lee YC, et al. Stimulation of pancreatic b-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 2006;188:481-492
74. List JF, He H, Habener JF. Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin. Regul Pept 2006;134:149-157
75. Zhou J, Wang X, Pineyro MA, et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulinproducing cells. Diabetes 1999;48:2358-2366
76. Masamune A, Satoh M, Kikuta K, et al. Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells. World J Gastroenterol 2005;11:6144-6151
77. Drucker DJ. Minireview: The glucagon-like peptides. Endocrinology 2001;142:521-527
78. Xu G, Kaneto H, Lopez-Avalos MD, et al. GLP-1/exendin-4 facilitates b-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract 2006;73:107-110
79. Kikuta K, Masamune A, Satoh M, et al. 4-Hydroxy-2, 3-nonenal activates activator protein-1 and mitogen-Activated protein kinases in rat pancreatic stellate cells. World J Gastroenterol 2004;10:2344-2351
80. Masamune A, Kikuta K, Satoh M, et al. Alcohol activates activator protein-1 and mitogen-Activated protein kinases in rat pancreatic stellate cells. J Pharmacol Exp Ther 2002;302:36-42
81. Butler AE, Campbell-Thompson M, Gurlo T, et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagonproducing neuroendocrine tumors. Diabetes 2013;62:e19-e22.